# | Drug | Count |
---|---|---|
0 | TACROLIMUS | 1687 |
1 | TACROLIMUS CAPSULES | 1563 |
2 | MYCOPHENOLATE MOFETIL | 1302 |
3 | PREDNISONE | 980 |
4 | PREDNISOLONE | 612 |
5 | RITUXIMAB | 534 |
6 | CYCLOPHOSPHAMIDE | 467 |
7 | METHYLPREDNISOLONE | 370 |
8 | CYCLOSPORINE | 359 |
9 | FLUDARABINE PHOSPHATE | 343 |
# | Drug | Count | Frequency |
---|---|---|---|
0 | GANCICLOVIR SODIUM | 173 | 0.0247 |
1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 147 | 0.0244 |
2 | TACROLIMUS CAPSULES | 1563 | 0.0236 |
3 | (EMAPALUMAB-LZSG) | 1 | 0.0227 |
4 | BASILIXIMAB | 170 | 0.0218 |
5 | CIDOFOVIR ANHYDROUS | 18 | 0.0200 |
6 | MYCOPHENILIC ACID | 173 | 0.0199 |
7 | BUSULFAN | 217 | 0.0173 |
8 | TACROLIMUS | 1687 | 0.0170 |
9 | MYCOPHENOLATE MOFETIL | 1302 | 0.0162 |
# | Drug class | Count |
---|---|---|
0 | Corticosteroid [EPC] | 1835 |
1 | Alkylating Drug [EPC] | 671 |
2 | CD20-directed Cytolytic Antibody [EPC] | 536 |
3 | Calcineurin Inhibitor Immunosuppressant [EPC] | 359 |
4 | Purine Antimetabolite [EPC] | 328 |
5 | Kinase Inhibitor [EPC] | 318 |
6 | mTOR Inhibitor Immunosuppressant [EPC] | 280 |
7 | Folate Analog Metabolic Inhibitor [EPC] | 274 |
8 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 270 |
9 | Nucleoside Analog Antiviral [EPC] | 180 |
# | Drug class | Count | Frequency |
---|---|---|---|
0 | Immunoglobulin G [EPC] | 147 | 0.0244 |
1 | Interleukin-2 Receptor Blocking Antibody [EPC] | 170 | 0.0218 |
2 | Interferon gamma Blocker [EPC] | 1 | 0.0217 |
3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 270 | 0.0208 |
4 | Antimetabolite Immunosuppressant [EPC] | 173 | 0.0199 |
5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 15 | 0.0138 |
6 | Selective T Cell Costimulation Blocker [EPC] | 38 | 0.0138 |
7 | CD52-directed Cytolytic Antibody [EPC] | 167 | 0.0107 |
8 | Interleukin-6 Antagonist [EPC] | 2 | 0.0076 |
9 | Purine Antimetabolite [EPC] | 328 | 0.0052 |